Finance
Radiation therapy centers operator closes $100 million debt financing
Published in Cancer Weekly, January 17th, 2006
The company has added a $50 million accordion feature to the facility, which allows it to increase the aggregate principal amount of the term B financing to $150 million, at the company's option.
The $100 million term B loan has an initial interest rate spread of 200 basis points, with the opportunity to permanently reduce the spread to 175 basis points after 6 months, provided the company's leverage ratio is below 2:1.
The company used the proceeds of the term B loan to pay off its pre-existing term A loan as well as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-01-17)
More Articles from Cancer Weekly
- Brain Cancer
Contrast-enhanced MR imaging at 3.0 T yielded higher CNR than at 1.5 T - Breast Cancer
Human embryonic SC genes OCT4/NANOG/STELLAR/GDF3 expressed in seminoma and breast cancer - Cancer Inhibition
5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibited cancer cells - Fitness & Wellness
QoL was lower in non-Hodgkin lymphoma survivors not meeting health exercise guidelines - Melanoma
3D MRI delineated tumor shape of ocular melanoma - Acoustic Neuroma
Image distortion of neuromas treated with gamma knife radiosurgery examined - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
